Chemotherapy response in primary peritoneal small cell carcinoma
This case underscores the importance of a multidisciplinary approach and patient-centered care in managing rare cancers like primary peritoneal SCC. Further research is essential to clarify its molecular characteristics and improve therapeutic options.
Authors
- Mohammad Abu Shattal (ORCID: https://orcid.org/0000-0002-7380-6967)
- Sakhr Alshwayyat (ORCID: https://orcid.org/0000-0002-2295-1945)
- Mohammed Al‐mahdi Al‐kurdi (ORCID: https://orcid.org/0000-0002-1858-8450)
- Sundus Yahya Nser (ORCID: https://orcid.org/0009-0001-5696-0452)
- Majed M Abu Hajir
- Kholoud Alqasem (ORCID: https://orcid.org/0000-0001-5766-0710)
- Salsabeel Aljawabrah
- Ala’aldin Eqleem
Institutions
- University of Aleppo (SY)
- University of Jordan (JO)
- Applied Science Private University (JO)
- Hashemite University (JO)
- King Hussein Cancer Center (JO)
- Kern Medical Center (US)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1007/s12672-025-03433-y
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35